ASX:UCMUscom Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Uscom Limited Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add Add Compare Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsInsider TradesHeadlines Uscom Limited designs, develops, manufactures, and markets non-invasive cardiovascular and pulmonary medical devices worldwide. The company offers USCOM 1A, a non-invasive hemodynamic monitor that measures cardiovascular function using Doppler ultrasound; BP+, a supra-systolic oscillometric central blood pressure monitor that measures blood pressure and blood pressure waveforms at the heart, as well as in the arm; and SpiroSonic, a pulmonary function testing device based on multi-path ultrasound technology. It serves hospitals and other medical care locations through a network of distribution partners. The company was incorporated in 1999 and is headquartered in Sydney, Australia.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Uscom. Previous Next 2.2 Community Rank Outperform VotesUscom has received 4 “outperform” votes. (Add your “outperform” vote.)Underperform VotesUscom has received 5 “underperform” votes. (Add your “underperform” vote.)Community SentimentUscom has received 55.56% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Uscom and other stocks. Vote “Outperform” if you believe UCM will outperform the S&P 500 over the long term. Vote “Underperform” if you believe UCM will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldUscom does not currently pay a dividend.Dividend GrowthUscom does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Uscom insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.44 out of 5 stars Industry, Sector and Symbol Stock Exchange ASX Industry Medical Devices Sub-IndustryN/A SectorMedical Current SymbolASX:UCM Previous Symbol CUSIPN/A CIKN/A Webwww.uscom.com.au Phone61 2 9247 4144Debt Debt-to-Equity Ratio51.20 Current Ratio3.14 Quick Ratio2.15Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$3.12 million Price / Sales0.00 Cash FlowN/A Price / Cash FlowN/A Book ValueA$0.02 per share Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous EmployeesN/A Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable Receive UCM News and Ratings via Email Sign-up to receive the latest news and ratings for UCM and its competitors with MarketBeat's FREE daily newsletter. Uscom (ASX:UCM) Frequently Asked Questions Has Uscom been receiving favorable news coverage? Headlines about UCM stock have trended somewhat negative on Sunday, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Uscom earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news articles about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news aboutUscom. Who are some of Uscom's key competitors? Some companies that are related to Uscom include Cannabix Technologies (BLO), Cochlear (CHEOF), COCHLEAR LTD/ADR (CHEOY), Ellex Medical Lasers (ELXMF), GN Store Nord A/S (GGNDF), Ion Beam Applications (IOBCF), Micro-X (MX1), Nemaura Medical (NMRD), Neuronetics (VMD), Neuroone Medical Technologies (NMTC), Ortho Regenerative Technologies (ORTH), OTCMKTS:ODYY (ODYY), PetVivo (PETV), Protech Home Medical (PTQQF) and Rafina Innovations (VICA). View all competitors. Who are Uscom's key executives? Uscom's management team includes the following people: Dr. Robert Allan Phillips DMU, Ph.D.(Med), AMS, MPhil (Med), FASE, FIR, Founder, Exec. Chairman, CEO & Chief Scientist (Age 67)Mr. Brett Crowley, Company Sec. & Non-Exec. Director (Age 63)Mr. Nicholas Schicht, Gen. Mang. (Age 54) What is Uscom's stock symbol? Uscom trades on the ASX under the ticker symbol "UCM." How big of a company is Uscom? Uscom has a market capitalization of $0.00 and generates $3.12 million in revenue each year. What is Uscom's official website? The official website for Uscom is www.uscom.com.au. How can I contact Uscom? The company can be reached via phone at 61 2 9247 4144. This page was last updated on 5/31/2020 by MarketBeat.com Staff
